- Home
- THTX vs LUCD Comparison
THTX vs LUCD Comparison
Compare THTX & LUCD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THTX
- LUCD
- Stock Information
- Founded
- THTX 1993
- LUCD 2018
- Country
- THTX Canada
- LUCD United States
- Employees
- THTX N/A
- LUCD N/A
- Industry
- THTX Biotechnology: Pharmaceutical Preparations
- LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- THTX Health Care
- LUCD Health Care
- Exchange
- THTX Nasdaq
- LUCD Nasdaq
- Market Cap
- THTX 119.1M
- LUCD 140.7M
- IPO Year
- THTX N/A
- LUCD 2021
- Fundamental
- Price
- THTX $2.53
- LUCD $1.26
- Analyst Decision
- THTX Hold
- LUCD Strong Buy
- Analyst Count
- THTX 1
- LUCD 4
- Target Price
- THTX N/A
- LUCD $3.94
- AVG Volume (30 Days)
- THTX 139.5K
- LUCD 1.3M
- Earning Date
- THTX 07-09-2025
- LUCD 08-11-2025
- Dividend Yield
- THTX N/A
- LUCD N/A
- EPS Growth
- THTX N/A
- LUCD N/A
- EPS
- THTX N/A
- LUCD N/A
- Revenue
- THTX $88,666,000.00
- LUCD $4,173,000.00
- Revenue This Year
- THTX N/A
- LUCD $91.46
- Revenue Next Year
- THTX $15.13
- LUCD $213.42
- P/E Ratio
- THTX N/A
- LUCD N/A
- Revenue Growth
- THTX 13.52
- LUCD 39.89
- 52 Week Low
- THTX $1.12
- LUCD $0.68
- 52 Week High
- THTX $3.13
- LUCD $1.80
- Technical
- Relative Strength Index (RSI)
- THTX 49.00
- LUCD 46.57
- Support Level
- THTX $2.38
- LUCD $1.21
- Resistance Level
- THTX $2.68
- LUCD $1.34
- Average True Range (ATR)
- THTX 0.09
- LUCD 0.08
- MACD
- THTX -0.02
- LUCD -0.01
- Stochastic Oscillator
- THTX 51.72
- LUCD 50.00
About THTX Theratechnologies Inc.
Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States. It generates revenue from one customer RxCrossroads, which is domiciled in the United States.
About LUCD Lucid Diagnostics Inc.
Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.